Does ABIRATERONE Cause Interstitial lung disease? 102 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Interstitial lung disease have been filed in association with ABIRATERONE (Abiraterone Acetate). This represents 0.3% of all adverse event reports for ABIRATERONE.
102
Reports of Interstitial lung disease with ABIRATERONE
0.3%
of all ABIRATERONE reports
28
Deaths
67
Hospitalizations
How Dangerous Is Interstitial lung disease From ABIRATERONE?
Of the 102 reports, 28 (27.5%) resulted in death, 67 (65.7%) required hospitalization, and 8 (7.8%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABIRATERONE. However, 102 reports have been filed with the FAERS database.
What Other Side Effects Does ABIRATERONE Cause?
Death (5,623)
Fatigue (1,928)
Drug ineffective (1,732)
Therapy cessation (1,602)
Prostatic specific antigen increased (1,581)
Disease progression (1,098)
Hospitalisation (1,034)
Hot flush (989)
Asthenia (891)
Off label use (859)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ABIRATERONE Alternatives Have Lower Interstitial lung disease Risk?
ABIRATERONE vs ABIRATERONE\ABIRATERONE
ABIRATERONE vs ABOBOTULINUMTOXINA
ABIRATERONE vs ABRAXANE
ABIRATERONE vs ABROCITINIB
ABIRATERONE vs ACALABRUTINIB